Psychiatr News September 1, 2006
Volume 41, Number 17, page 13
© 2006 American Psychiatric Association
Psychiatric Practice & Managed Care APA Office of Healthcare Systems
and Financing
|
Is Part D Working Better? Share Your Experience
According to Irvin L. "Sam" Muszynski, J.D., director of APA's
Office of Healthcare Systems and Financing (OHSF), the jury is still out on
whether most of the problems encountered with the launch of Medicare's new
Part D prescription drug benefit have been resolved. Are beneficiaries now
getting access to the medications they need? Or have physicians and patients
simply given up the quest to obtain them?
"All we know at this point," said Muszynski, "is that
we've had some success in making the Centers for Medicare and Medicaid
Services [CMS] aware of the problems facing psychiatrists who are trying to
maintain their Medicare and dual-eligible Medicaid patients on the drugs they
were taking before they entered Part D. We've been able to get a number of
concessions from CMS when we've explained the kind of problems that are
arising.
"However, we need to keep hearing from APA members about the
problems they're encountering if we are to continue making progress with
CMS. What we've found is that CMS is willing to solve problems on a
case-by-case basis and to intervene with plans when complaints can be
documented."
One important change that has resulted from OHSF advocacy is that CMS
issued a clarification explaining that coverage of medications cannot be
denied because the prescribed dose exceeds the dose approved by the FDA
(Psychiatric News, July 21). Part D prescription drug plans (PDPs)
had been routinely denying access to brand-name medications that were
prescribed at doses higher than those approved by the FDA. Although the reason
given for these denials was often "patient safety," the same kind
of edits were rarely being used for generic drugs.
An issue that OHSF is now exploring with CMS is how physicians can be
compensated for the extra time they are putting in so that their patients can
have access to needed medications under Part D. Although CMS reports quick
responses to physician requests, OHSF is hearing from APA members that they
are still experiencing long waits on the telephone for prior authorizations.
Such extensive expenditure of physician time had not been anticipated in the
CPT coding system that forms the basis for determining Medicare payments.
As the first year of Part D nears its close (open season for Medicare
beneficiaries to switch drug plans for 2007 is November 15 to December 31,
2006), Muszynski reminds APA members that any exceptions for drug coverage
obtained in 2006 will probably have to be requested again for coverage in
2007. Although PDPs have the option of continuing exceptions beyond the plan
year, it seems unlikely that many of them will do so.
Please inform OHSF about any problems you're having with Part D so staff
can continue having a dialog with CMS based on actual problems and work toward
their resolution.
Send e-mails to
partd{at}psych.org
or call (866) 882-6227. For the latest Part D information for psychiatrists,
go to
<www.mentalhealthpartd.org>.
Get information about faster international access.
Privacy Policy
Copyright © 2006
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
| 
